Rebecka L.
- Country
- Sweden
- Department
- Medicine
Research Overview
Data & Insights
Has run more than one trial at 0 of 9 partner sites.
Specializations
Hematologic Malignancies
The investigator focuses on B‑cell lymphomas, with a particular emphasis on Follicular Lymphoma. Research also addresses aggressive entities such as Diffuse Large B‑Cell Lymphoma. Plasma‑cell disorders are represented by studies on Multiple Myeloma. Chronic lymphoid neoplasms including Chronic Lymphocytic Leukemia are a further priority. Maintenance strategies after stem‑cell transplantation are explored in the context of Mantle Cell Lymphoma.
- Follicular Lymphoma
- Diffuse Large B‑Cell Lymphoma
- Mantle Cell Lymphoma
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
Therapeutic investigations include novel immunomodulators and targeted agents for relapsed disease.
Breast Cancer Therapeutics
Clinical work targets HER2‑driven disease, exemplified by studies on HER2‑positive Breast Cancer. Triple‑negative subtypes are investigated through trials on Triple Negative Breast Cancer. Hormone‑receptor positive tumors are addressed via research on Hormone Receptor Positive Breast Cancer. Early‑stage neoadjuvant approaches are evaluated for improved pathological response. Biomarker‑guided endocrine strategies are explored for disease recurrence prevention.
- HER2‑positive Breast Cancer
- Triple Negative Breast Cancer
- Hormone Receptor Positive Breast Cancer
Efforts include integrating antibody‑drug conjugates and targeted oral agents into standard regimens.
Infectious Disease Management
Antibiotic stewardship is central to work on resistant urinary infections, such as Febrile Urinary Tract Infection. Prosthetic joint infections are examined through studies on Periprosthetic Joint Infection. Bloodstream infections caused by Gram‑positive organisms are represented by research on Staphylococcus aureus Bacteraemia. Emerging viral threats are addressed via trials on Tick‑Borne Encephalitis. Novel susceptibility testing methods guide therapeutic choices.
- Febrile Urinary Tract Infection
- Periprosthetic Joint Infection
- Staphylococcus aureus Bacteraemia
- Tick‑Borne Encephalitis
Outcomes focus on infection resolution, resistance mitigation, and patient safety.
Autoimmune & Inflammatory Disorders
Immune‑mediated joint disease is a key area, highlighted by investigations into Rheumatoid Arthritis. Systemic autoimmunity is represented by studies on Systemic Lupus Erythematosus. Gastrointestinal inflammation is addressed through work on Inflammatory Bowel Disease. Skin and joint manifestations are examined via trials on Psoriatic Arthritis. Allergic airway disease is explored in research on Allergic Rhinitis.
- Rheumatoid Arthritis
- Systemic Lupus Erythematosus
- Inflammatory Bowel Disease
- Psoriatic Arthritis
- Allergic Rhinitis
Therapies under evaluation include biologics and targeted small molecules.
Cardiovascular & Metabolic Disorders
Arrhythmia‑related stroke prevention is investigated through studies on Atrial Fibrillation. Glucose regulation in chronic disease is addressed via trials on Type 2 Diabetes. Blood pressure control is a focus of research on Hypertension. Overall cardiovascular risk reduction is examined in the context of Cardiovascular Disease. Renal impairment associated with heart disease is represented by work on Chronic Kidney Disease.
- Atrial Fibrillation
- Type 2 Diabetes
- Hypertension
- Cardiovascular Disease
- Chronic Kidney Disease
Comparative studies of anticoagulants and lipid‑lowering agents aim to improve clinical outcomes.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.